Reeti Behera
YOU?
Author Swipe
View article: Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance Open
View article: Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
View article: Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
View article: Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
View article: Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-de…
View article: Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
View article: Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
View article: Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-de…
View article: Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
View article: Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
View article: Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
View article: Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
View article: Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis Open
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (<55 years old) for reasons that are not completely understood. Analysis of the young and aged secretome from human dermal fibroblast…
View article: Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Supplementary Figures and Legends.
View article: Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Aged BODIPY-C12 fibroblasts with GFP-tagged melanoma cells
View article: Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (Significance:These data show that melanoma cells take up lipids from aged fibroblasts, via FATP2, and u…
View article: Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (Significance:These data show that melanoma cells take up lipids from aged fibroblasts, via FATP2, and u…
View article: Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Supplementary Figures and Legends.
View article: Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Young BODIPY-C12 fibroblasts with GFP-Tagged melanoma cells showing lipid uptake
View article: Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Aged BODIPY-C12 fibroblasts with GFP-tagged melanoma cells
View article: Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Young BODIPY-C12 fibroblasts with GFP-Tagged melanoma cells showing lipid uptake
View article: Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Supplementary Figures and Legends.
View article: Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (Significance:These data show that melanoma cells take up lipids from aged fibroblasts, via FATP2, and u…
View article: Supplementary Movie 1 (SM1) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 1 (SM1) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Young BODIPY-C12 fibroblasts with GFP-Tagged melanoma cells showing lipid uptake
View article: Supplementary Movie 1 (SM1) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 1 (SM1) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Young BODIPY-C12 fibroblasts with GFP-Tagged melanoma cells showing lipid uptake
View article: Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Supplementary Figures and Legends.
View article: Supplementary Movie 2 (SM2) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 2 (SM2) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Aged BODIPY-C12 fibroblasts with GFP-tagged melanoma cells
View article: Supplementary Movie 2 (SM2) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Supplementary Movie 2 (SM2) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 Open
Aged BODIPY-C12 fibroblasts with GFP-tagged melanoma cells
View article: Supplementary Figure 4 from Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity
Supplementary Figure 4 from Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity Open
Supplementary Figure 4 - rWnt5A and Myeloid-Wnt5A Promotes an Immunosuppressive TME in Peripheral Blood and Lungs in vivo
View article: Supplementary Figure 5 from Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity
Supplementary Figure 5 from Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity Open
Supplementary Figure 5 - Myeloid Wnt5A Does Not Influence CXCR2 Expression on MDSCs